A recent social-media video advertisement from a commercial whole-body MRI provider begins by asking:
“Keep getting told your symptoms are ‘normal’?”
Later in the advertisement, viewers are asked, “Do you know what’s really happening inside your body?” before being told:
“In just one hour, XXXX scans 13 vital systems — without a referral. Receive a detailed report and take proactive control of your health before small issues become big problems.”
Viewed as a whole, the video advertisement is emotionally persuasive. Clinically, however, its message is confused, inappropriate and potentially misleading. A separate advertisement from the same provider repeats the same strategy, asking whether people are tired of hearing ‘it’s probably nothing’ and promoting ‘One Scan. 60 Minutes. 500+ Conditions Screened’ as ‘Peace of Mind in 60 Minutes.’
Across the video and the separate advertisement, the campaign speaks directly to people with unresolved symptoms who may feel dismissed by previous medical care, then presents a broad, one-hour scan – available without referral – as the means to discover what is ‘really happening,’ screen for more than 500 conditions and intervene before ‘small issues become big problems.’ It collapses symptomatic diagnosis, asymptomatic screening, reassurance and prevention into a single commercial promise.
Figure 1. Left and centre: selected snapshots from the video advertisement. Right: a separate advertisement from the same provider. Together, they use unresolved symptoms and fear of being dismissed to promote a one-hour whole-body MRI as screening, reassurance, early detection and prevention.
Screening is performed in people who do not have symptoms, with the aim of detecting disease before it becomes clinically apparent. Once someone has symptoms, the task is no longer asymptomatic screening. It is diagnosis.
That distinction is not academic. It determines what questions should be asked, which examination should be performed, how the scan should be designed and what should happen after the result.
Persistent symptoms require diagnosis, not a generic scan
Symptoms are what a patient experiences. They may arise from serious disease, a benign condition, normal physiological variation or a problem that has not yet been adequately investigated. A symptom cannot simply be declared “normal” by a scan.
When someone has persistent or unexplained symptoms, the appropriate response is not necessarily to scan more of their body. It is to ask a better clinical question.
That process usually requires:
- a careful medical history and examination;
- consideration of the likely causes and their relative risks;
- selection of the most appropriate imaging modality;
- an imaging protocol designed for the specific clinical problem;
- correlation of the findings with the patient’s symptoms; and
- a plan for further investigation or management.
Depending on the clinical question, the appropriate examination may be a dedicated MRI, spectral CT, ultrasound, mammography, endoscopy, blood testing, physiological assessment or a combination of investigations.
Whole-body MRI can contribute valuable information in selected patients. It is not a universal substitute for clinical assessment or targeted diagnostic imaging.
A whole-body screening MRI is not a collection of dedicated diagnostic MRIs
Whole-body MRI covers an enormous anatomical area within a limited examination time (especially in the case of this provider who condense the scan into 60 minutes). Every protocol therefore involves compromises in sequence selection, spatial resolution, tissue contrast, anatomical coverage and acquisition time.
A carefully developed whole-body MRI can provide an exceptionally valuable overview of multiple organ systems. When it includes high-quality anatomical imaging, technically robust whole-body diffusion-weighted imaging and experienced multi-organ interpretation, it can identify important abnormalities before they would otherwise have been detected.
However, anatomical coverage is not the same as diagnostic fidelity.
Saying that a whole-body scan includes the abdomen does not mean it has the same sensitivity for subtle pancreatic disease as a dedicated pancreatic MRI. Including the brain does not make it equivalent to a properly protocolled neurological examination. Scanning the pelvis does not automatically provide a high-quality prostate, rectal, gynaecological or musculoskeletal assessment.
The relevant question is not simply whether an organ was included within the field of view. It is whether the sequences, spatial resolution, contrast characteristics and technical quality were sufficient to detect the pathology being sought.
This principle applies throughout the body.
Whole-body MRI also has recognised limitations in the lungs, coronary arteries, bowel, skin and several forms of early or microscopic disease. It does not replace established breast, cervical or bowel cancer screening. International ONCO-RADS guidance emphasises appropriate acquisition, whole-body diffusion-weighted imaging, structured interpretation, reader expertise and clear pathways for managing abnormalities.[1]
A responsible provider should explain these limitations before the examination. A broad scan should never be presented as proof that every possible cause of a patient’s symptoms has been adequately investigated.
Why this advertisement is potentially misleading
The concern is not confined to one phrase, one snapshot or even one video. Health advertising must be considered by the overall impression it creates. Here, the same clinically confused proposition appears across separate advertisements, making the campaign’s cumulative message inappropriate and potentially misleading.
The video engages people who feel dismissed or remain concerned about unresolved symptoms, then supplies the commercial answer: a scan of ‘13 vital systems’ in ‘just one hour,’ ‘without a referral,’ followed by a detailed report and the suggestion that acting now may prevent ‘small issues’ becoming ‘big problems.’ The separate advertisement reinforces that message by pairing ‘it’s probably nothing’ with ‘500+ Conditions Screened’ and ‘Peace of Mind in 60 Minutes.’ The cumulative implication is that this broadly marketed scan may reveal what previous medical care has missed, rule out hundreds of possible conditions and alter the course of disease through early action.
Each component compounds the concern. ‘What’s really happening inside your body?’ implies unusual diagnostic insight. ‘13 vital systems’ and ‘500+ conditions screened’ emphasise breadth without explaining the variable fidelity of each organ assessment or what ‘screened’ actually means. ‘Without a referral’ removes a layer of clinical selection, while ‘before small issues become big problems’ and ‘peace of mind’ imply preventive benefit and reliable reassurance that cannot be assumed merely because a broad scan has been performed. These implications require considerably more qualification than the advertisements provide.
A whole-body screening examination could miss the cause of a patient’s symptoms if it does not include the sequences, resolution, contrast administration, dynamic assessment or complementary modality needed for that particular condition. A reassuring result could then delay the targeted investigation the patient actually requires.
The opposite problem also occurs. Broad imaging can detect incidental or indeterminate abnormalities that require further scans, specialist review or biopsy, even when they ultimately prove benign. Patients should understand this possibility before purchasing the examination, together with the provider’s pathway for resolving such findings.
Whole-body MRI cannot responsibly be reduced to a count of body systems or conditions and an appealing claim about early detection or peace of mind. Breadth of coverage is not proof of diagnostic completeness, a screening examination cannot rule out every cause of symptoms, and earlier detection does not automatically mean that a clinically important outcome can be prevented.
Medical imaging should be medically led
The deeper problem is the increasing tendency to market complex medical services as technology products.
A MRI scanner and a polished website can create the appearance of clinical authority. They do not, by themselves, establish it.
The quality of whole-body MRI depends on much more than access to the machine. It depends on:
- appropriate patient selection;
- clinical governance;
- a protocol developed and validated for the particular scanner;
- experienced MRI radiographers;
- specialist radiologists with broad multi-organ expertise;
- an understanding of the examination’s limitations;
- integration with established screening programs;
- access to targeted MRI, CT, ultrasound and other investigations; and
- a clinically coherent pathway when an abnormality is identified.
A technology-led business model begins with a product – whole-body MRI – and then markets that product to different groups of consumers: people concerned about cancer, healthy people seeking reassurance and patients with unresolved symptoms.
A medical model begins with the person, their risk and the clinical question. It then determines whether whole-body MRI is appropriate, whether a dedicated investigation would be better, or whether several complementary modalities are required.
The name of the scan may be marketed the same. The quality and purpose of the service are not.
This is the danger when medical imaging is shaped primarily by technology entrepreneurs and marketing teams rather than clinicians who understand the disease processes being investigated. The website may be sophisticated and the branding reassuring while the underlying clinical proposition remains poorly defined.
In medicine, presentation cannot substitute for diagnostic reasoning. Repetition across separate advertisements also makes this harder to dismiss as one unfortunate line of copy. The campaign suggests one of two serious problems: either the provider does not understand the distinction between asymptomatic screening and symptomatic diagnosis, or it understands that distinction but is willing to blur it in order to sell the scan. The available advertisements cannot establish which explanation is correct, but neither should reassure patients, referrers or regulators.
Australian advertising requirements apply to the service, not merely the doctor
Section 133 of the Health Practitioner Regulation National Law prohibits advertising a regulated health service in a way that is false, misleading or deceptive, or likely to be misleading or deceptive. It also prohibits advertising that creates an unreasonable expectation of beneficial treatment or encourages indiscriminate or unnecessary use of regulated health services.[2,3]
These obligations are not limited to individual medical practitioners. Ahpra states that the advertising requirements apply to registered practitioners, unregistered individuals and businesses advertising regulated health services.[3,4]
Whether the advertisements formally breach the National Law is a matter for the relevant regulator after considering the complete video, the separate advertisement, the surrounding campaign and the evidence supporting their express and implied claims. Nevertheless, their cumulative presentation raises legitimate questions:
- Do the advertisements clearly distinguish asymptomatic screening from investigation of persistent symptoms?
- Do the claims to scan ‘13 vital systems’ and screen for ‘500+ conditions’ adequately explain that anatomical coverage is not equivalent to dedicated diagnostic assessment or exclusion of each condition?
- Is “without a referral” presented in a way that could encourage self-selection without an adequate clinical question or consideration of a more appropriate test?
- Could “what’s really happening inside your body” create an unreasonable expectation of diagnostic completeness?
- Could “before small issues become big problems” imply that detecting an abnormality earlier will necessarily prevent progression or improve health outcomes?
- Are the examination’s material limitations, false-negative risk, incidental findings and need for targeted follow-up sufficiently prominent in the advertisements themselves?
- Is the overall impression created by the campaign clinically accurate?
The overall impression is important. These advertisements create vulnerability and urgency, then offer the product as the solution. Qualifications elsewhere on a website may not correct the much stronger and repeated message delivered by the campaign itself.
Whole-body MRI deserves better
This is not an argument against whole-body MRI.
Performed correctly, for an appropriate patient and within a medically governed pathway, whole-body MRI is one of the most powerful imaging examinations available. It can assess many anatomical regions without ionising radiation, depict marrow and soft-tissue abnormalities particularly well and provide diffusion-weighted information across much of the body.
Its value, however, depends on understanding both what it can detect and what it cannot.
If someone has persistent symptoms, they need a diagnostic pathway built around those symptoms.
If someone without symptoms is considering screening, they need an evidence-informed discussion about their individual risk, the potential benefits and limitations of the examination, incidental findings, false reassurance and the established screening tests that whole-body MRI does not replace.
These are different patients requiring different medical conversations. Combining them repeatedly within emotionally compelling sales messages may be commercially effective, but it is neither clinically coherent nor ethically appropriate.
Whole-body MRI should be provided as medicine – not sold as a premium wellness experience. A scanner and a fancy website are not enough. Patients deserve appropriate selection, a technically rigorous examination, expert interpretation, honest communication of limitations and access to the wider diagnostic pathway required to act on the result.
The future of whole-body MRI should be shaped by clinicians who understand its extraordinary capabilities, its limitations and the consequences of getting either wrong.
References
- Petralia G, Koh DM, Attariwala R, et al. Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): guidelines for the acquisition, interpretation, and reporting of whole-body MRI for cancer screening. Radiology. 2021;299(3):494–507. ONCO-RADS publication
- Australian Health Practitioner Regulation Agency. Advertising and the law: section 133 of the National Law. Advertising and the law
- Australian Health Practitioner Regulation Agency. Summary of the advertising requirements. Summary of advertising requirements
- Australian Health Practitioner Regulation Agency. Guidelines for advertising a regulated health service. Advertising guidelines
